ALKBH5 and familial pancreatic carcinoma: He Y et al found that the m6A eraser protein ALKBH5 can inhibit pancreatic cancer progression by reducing the methylation of long non-coding RNA (lncRNA) KCNK15-AS1, suggesting it may be a potential therapeutic target for pancreatic cancer (He et al., 2018).